COLUMBUS, Ohio, June 25 /PRNewswire-USNewswire/ -- Battelle is strengthening its customer-focused biomarker services portfolio to pharmaceutical, biotechnology, medical device, and government clients, and Kevin Xie will lead those efforts as Battelle's Vice President of Biomarker Services.
Battelle offers a suite of biomarker services, including biomarker discovery, qualification, and validation services to help our clients better define molecular mechanisms of diseases, toxicity, and therapeutic responses.
Xie brings an impressive background to Battelle. He has expertise in pharmaceutical, medical device and diagnostics spanning a number of therapeutic areas including oncology, immunology and infectious diseases.
He has been the director and head of global business development of specialty pharmaceuticals at Boehringer Ingelheim Corp. for the last two years. For four years prior to that, Xie was the director and head of global business development for diabetes care for Bayer Healthcare. At Vertex Pharmaceuticals from 2000-02, he was the director of licensing and business development. For the three years prior to that, Xie was the director of business development and strategic planning at Baxter Healthcare.
Xie earned a Ph.D. in molecular biology at Yale University as well as an MBA in finance and strategy. He earned bachelor's and master's degrees from Fudan University in Shanghai, China.
"We are pleased to hire Kevin not only because we believe he is a quality person but because his diverse background made him the perfect candidate for the job," said Barbara Kunz, President of Battelle's Health and Life Sciences Global Business. "The mix of business, biology, and pharmacological work in his career will make him successful here."
Battelle's Global Health and Life Sciences Global Business delivers a comprehensive set of R&D services to solve complex challenges for government health agencies and medical device, biotechnology, and pharmaceutical firms. Including its national laboratories, Battelle oversees over $200 million annually in health and life sciences research and development contributing to advances in medical devices, pharmaceuticals, public health, and next-generation diagnostics and therapeutics.
Battelle is the world's largest non-profit independent research and development organization, providing innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management, National Security, Energy Technology, and Health and Life Sciences. It advances scientific discovery and application by conducting $4 billion in global R&D annually through contract research, laboratory management, and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 20,400 employees in more than 120 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security.
Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science and math education.
Contact National Media Relations Manager Katy Delaney at (410) 306-8638 or firstname.lastname@example.org or T.R. Massey, Media Relations Specialist, at (614) 424-5544 or email@example.com for more information.
Copyright©2008 PR Newswire.
All rights reserved